产品详情
Targets
Target | Value |
---|---|
VEGFR2/KDR | IC50: 37nM |
VEGFR1/FLT1 | IC50: 77nM |
VEGFR2/Flk1 | IC50: 270nM |
PDGFRβ | IC50: 580nM |
VEGFR3/FLT4 | IC50: 660nM |
c-Kit | IC50: 730nM |
c-Fms | IC50: 1.4μM |
In vitro | DMSO | 77 mg/mL (183.45 mM) | |
Water | 9 mg/mL (21.44 mM) | ||
Ethanol | 5 mg/mL (11.91 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.83 mL | 119.13 mL | 238.27 mL |
0.5 mM | 4.77 mL | 23.83 mL | 47.65 mL |
1 mM | 2.38 mL | 11.91 mL | 23.83 mL |
5 mM | 0.48 mL | 2.38 mL | 4.77 mL |
*The above data is based on the productmolecular weight 419.7 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10967 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 419.7 |
Formula | C20H17Cl3N4 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 212141-51-0 |
Synonyms | Vatalanib,PTK787,PTK/ZK |
SMILES | C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4.Cl.Cl |
产品资料
产品标签
Product Questions
Product Questions
Vandetanib (ZD6474)
Vandetanib (ZD6474)是一种VEGFR和EGFR拮抗剂,是一种酪氨酸激酶抑制剂,对于HUVEC增殖,PC-9细胞和酪氨酸激酶活…
Apatinib (YN968D1)
Apatinib (YN968D1)是一种酪氨酸激酶抑制剂,可选择性抑制血管内皮生长因子受体2(VEGFR2,也称为KDR),后者…
Motesanib (AMG706)
Motesanib(AMG706)是一种多激酶抑制剂,可选择性靶向VEGF受体,血小板衍生的生长因子受体(PDGFRs)和Kit受体…
TSU-68 (Orantinib, SU6668)
TSU-68 (Orantinib,SU6668)在无细胞试验中具有8 nM的Ki对PDGFR自磷酸化的最大效力,但也强烈抑制Flk-1和FGFR1反磷酸…
BMS-690514
BMS-690514是一种有效的选择性表皮生长因子受体(EGFR),HER2和HER4抑制剂,以及VEGF受体激酶。
Regorafenib (BAY 73-4506)
Regorafenib (BAY 73-4506)是一种多激酶抑制剂,IC50为17、40和69 nM c-KIT,VEGFR2,B-Raf。Regorafenib(BAY 73-4506)是一种…
Raf265 derivative
Raf265 derivative是Raf265的衍生物,Raf265是一种口服,高度选择性的RAF和VEGFR激酶抑制剂,IC50为5至10μM。